Document ID: chunk:federal_register_of_legislation:F2024C01086:clause:1_15910
Version: federal_register_of_legislation:F2024C01086
Segment Type: clause
Provision Reference: sch 1 cl 15910
Character Range: 926549–929273

15910                                                 Megavoltage planning—level 3.1                                                                                                                                                                                                                                                                                                           4,142.70
                                                      Standard intensity modulated radiation therapy (IMRT) simulation and dosimetry for treatment planning, if:
                                                      (a) all of the following apply in relation to the simulation:
                                                      (i) treatment set‑up and technique specifications are in preparation for single‑dose level IMRT planning without motion management;
                                                      (ii) patient set‑up and immobilisation techniques are suitable for image volume data acquisition and reproducible IMRT treatment;
                                                      (iii) a high‑quality three‑dimensional image volume dataset is acquired in treatment position for the relevant region of interest to be planned and treated with image verification; and
                                                      (b) all of the following apply in relation to the dosimetry:
                                                      (i) the IMRT planning process is required to calculate dose to a single‑dose level volume structure and requires a dose‑volume histogram to complete the planning process;
                                                      (ii) based on review and assessment by a radiation oncologist, the IMRT planning process optimises the differential between target dose, organs at risk and normal tissue dose;
                                                      (iii) all relevant gross tumour volumes, clinical target volumes, planning target volumes and organs at risk are rendered as volumes and nominated with planning dose objectives;
                                                      (iv) organs at risk are nominated as planning dose constraints;
                                                      (v) dose calculations and dose‑volume histograms are generated in an inverse planned process using a specialised algorithm, with prescription and plan details approved and recorded with the plan;
                                                      (vi) a three‑dimensional image volume dataset is used for the relevant region to be planned and treated with image verification
                                                      Applicable once per course of treatment